Elemental Machines introduces its Usage Solution

The new Usage Solution is a novel product suite that has the potential to save millions in unnecessary spending within the life sciences to enable more efficient biotech/pharma drug discovery and manufacturing. CAMBRIDGE, MA  – Today, Elemental Machines continues its innovation within lab operations (LabOps) by launching its Usage Solution. The Usage Solution empowers agile [...]

Defined Bioscience Announces Formation of Scientific Advisory Board

San Diego, California — Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the Defined Bioscience team on the development and [...]

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

BOULDER, Colo. and BINYAMINA, Israel -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed [...]

Evonetix Appoints Colin McCracken as Chief Executive Officer

Cambridge, UK: EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the Company’s development and the commercialisation of its semiconductor-based DNA synthesis platform. Colin brings over 20 years’ experience in commercial and [...]

Bio-Rad Launches Foresight Pro Columns for Biotherapeutic Production

Validated, GMP Ready CHT Ceramic Hydroxyapatite Prepacked Columns to Support Process Chromatography Workflows HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological [...]

TWISTER, the universal mixing expert

/// IKA launches the first convertible mixing device. Staufen - IKA launches the first convertible mixing device. TWISTER is a single-position magnetic stirrer or multi-position magnetic stirrer. With one attachment, it reliably stirs the smallest volumes. With another attachment, it becomes a vortex shaker. And even before it's market launch, it received the Red Dot Award [...]

Ocean Insight Expands its Rochester, N.Y., Facility

The applied spectral solutions company prepares for growth in its Applied Systems business Orlando, Florida, USA  – Ocean Insight, the applied spectral knowledge company, is nearly doubling the size of its engineering, production and support facility in Rochester, N.Y., one of the country’s leading innovation hubs for optics and photonics. The expansion will bolster the [...]

ZEISS Innovation Center California wins local StopWaste Award

Active waste management and sustainability efforts get acknowledged by local county DUBLIN, California/United States -- ZEISS, the leading global optics and optoelectronics technology company, yesterday received the StopWaste Award for its ZEISS Innovation Center in Dublin, California. The StopWaste Award recognizes Alameda County organizations for their efforts in upstream waste prevention through reuse, recycling, and [...]

Bio-Works confirms order from new production customer for oligonucleotide manufacturing

Today, Bio-Works Technologies AB  has confirmed an order worth 2.3 MSEK for WorkBeads chromatography resins to be used in the manufacture of oligonucleotides. The customer is an American contract manufacturer who offers cGMP manufacturing to other pharmaceutical companies. They are part of a larger American conglomerate with 17 000 employees globally. Delivery is planned early [...]

With New Funding, Phase Genomics Seeks to Eliminate One of Biology’s Biggest Blind Spots

Armed with the world’s largest virus-bacteria interactome repository, Phase Genomics to engineer a predictive engine for the development of new therapies against drug-resistant biothreats SEATTLE --Phase Genomics, Inc., a leading developer of proximity ligation-based genomic solutions, today announced $5.5MM in combined non-dilutive funding from the Bill and Melinda Gates Foundation and the National Institute of [...]

Access IBO on Knowledge Center